CNSL — Cambridge Nutritional Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- £6.31m
- £1.79m
- £8.33m
- 13
- 98
- 37
- 45
Annual cashflow statement for Cambridge Nutritional Sciences, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.385 | -1.41 | -3.17 | -0.328 | 1.57 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -2.94 | -4.58 | -0.523 | -0.262 | 0.056 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.746 | 1.47 | -0.048 | 0.547 | -2.29 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.42 | -3.23 | -3.15 | 0.607 | -0.057 |
| Capital Expenditures | -2.83 | -1.48 | -0.153 | -0.059 | -0.382 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | 0.985 | 5.33 | -2.45 | 2.65 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.83 | -0.493 | 5.18 | -2.51 | 2.27 |
| Financing Cash Flow Items | -0.769 | -0.18 | -0.303 | -0.023 | -0.017 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 11.1 | -0.502 | 1.49 | -0.265 | -0.258 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.83 | -4.22 | 3.51 | -2.17 | 1.93 |